The Korea Food and Drug Administration(KFDA) recommended the Korean pharmaceutical industry the self-regulating test for 27 components of medicine being at risk for melamine contamination.

The KFDA, on 13 August, has distributed pamphlets titled 'Melamine Guide for the Pharmaceutical Industry' and urged the pharmaceutical industry's active cooperation.

This action was taken as the U.S.' Food and Drug Administration(FDA)' has lately offered 'Melamine Guide' warning against 27 components of medicine with potential melamine contamination to the U.S.' pharmaceutical industry after the fear of melamine-contaminated Chinese food products.

The major contents of the KFDA's melamine guide are as follows:

The drugmakers and companies importing raw materials for medicine are to execute the self-regulating test for 27 components to verify if they are containing melamine, to check the certification of melamine test for 27 components, and to monitor if their suppliers observe the KGMP(Korean Good Manufacturing Practice).

In addition, pharmaceutical wholesalers are also to check the certificaion of melamine test for 27 components.

The KFDA said, "18 raw materials for medicine, imported from China and including 8 compoents(Adenine and etc.), were collected first and tested for melamine. But no melamine was detected in them." [헬스코리아뉴스]

▶ 식약청, 멜라민 우려 27개 성분 조사 권고

Healthkoreanews 다른기사 보기